MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy (Q63400709)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy |
clinical trial |
Statements
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of MEDOTIXN® in Subject With Benign Masseteric Hypertrophy (English)
0 references
9 April 2018
0 references
31 August 2019
0 references
180
0 references
20 year
0 references
65 year
0 references